Lipum AB (publ)
556813-5999InactiveDeveloping first-in-class antibody drug candidate for chronic inflammatory diseases.
Overview
- 5–9
- Employees
- 750–999K SEK
- Revenue
- 2010
- Founded
Key Decision Makers
Ola Sandborgh
CEO
Description
Lipum AB (publ) is a clinical-phase biopharmaceutical company focused on developing novel treatments for chronic inflammatory diseases. Their lead drug candidate is SOL-116, a humanized monoclonal antibody designed to offer a unique mechanism of action. SOL-116 targets the Bile Salt-Stimulated Lipas...
Tags
Keywords
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556813599901
Decision Makers
1 contacts in FunnelfeedrOla Sandborgh
CEO
Similar Companies
20 similar companies in FunnelfeedrLipigon Pharmaceuticals AB
5–9 employeesClinical-stage company developing novel drugs for lipid disorders.
SynAct Pharma AB
5–9 employeesClinical-stage biotech resolving inflammation via novel oral therapies.
CANTARGIA AB
20–49 employeesDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
AQILION AB
5–9 employeesDeveloping innovative treatments for chronic inflammatory diseases via early-stage partnering.
Transient Pharma AB
0 employeesDeveloping peptide drugs targeting severe inflammatory diseases using natural templates.
Browse More
Lipum AB (publ) Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo